High Court challenge over decision to expand Luton Airport dismissed
8th Dec 2025 12:19
(Alliance News) - A High Court challenge against the government's approval of plans to expand Luton Airport has been dismissed by a judge. Read More
(Alliance News) - A High Court challenge against the government's approval of plans to expand Luton Airport has been dismissed by a judge. Read More
(Alliance News) - CRH PLC is to join the S&P 500 later this month, according to an index rebalancing announced on Friday. Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Monday, ahead of US consumer inflation expectations and comments from the Bank of England's deputy governor. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - Greengage & Co Group PLC on Monday said it intends to float on the Access segment of the Aquis Stock Exchange, alongside an accompanying fundraise. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Expects to announce initial faridoxorubicin phase 1b data in the salivary gland cancer indication next week Wednesday. Back in October, Avacta had said faridoxorubicin showed positive tolerability and safety in patents across both the every three weeks and every two weeks dosing regiments. Faridoxorubicin is a form of doxorubicin designed to reduce the systemic side effects of conventional chemotherapy and concentrate the active payload in the tumour microenvironment. Doxorubicin is a chemotherapy drug used to treat cancer. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer drugs has secured a place on the country's first-ever commercial insurance drug list. Read More
(Alliance News) - Fermi Inc on Monday reported a definitive deal for Xcel Energy Inc to supply electric services to its Matador energy grid project. Read More
(Alliance News) - The following stocks are the leading risers among London Main Market small-caps on Monday. Read More
(Alliance News) - Anglo American PLC on Monday said it has withdrawn a proposed amendment to raise minimum vesting of the share awards for 2024 and 2025 following shareholder concerns. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
(Alliance News) - Power Probe PLC on Monday said it is targetting a market valuation of GBP60.4 million when it starts trading on the London Stock Exchange's AIM market on Thursday. Read More
(Alliance News) - Smith & Nephew PLC on Monday announced targets for 2028, aiming for revenue and profit growth, as it is set to meet its goals for 2025. Read More